Case Report
Accepted on 06 Dec 2024
Severe Liver Injury Induced by Minocycline in Hepatitis B Patient: A Case Report
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516217
Type at least 3 characters
557 articles
Articles
Brief Research Report
Published on 05 Dec 2024
Clinical implications of a gain-of-function genetic polymorphism in DPYD (rs4294451) in colorectal cancer patients treated with fluoropyrimidines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516375
- 285 views
Original Research
Published on 04 Dec 2024
AH-6809 mediated regulation of lung adenocarcinoma metastasis through NLRP7 and prognostic analysis of key metastasis-related genes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1486265
- 163 views
Original Research
Published on 03 Dec 2024
Pharmacogenomic profiling of the South Korean population: Insights and implications for personalized medicine
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1476765
- 334 views
Correction
Accepted on 29 Nov 2024
Corrigendum: Overexpression of Nrf2 in bone marrow mesenchymal stem cells promotes B-cell acute lymphoblastic leukemia cells invasion and extramedullary organ infiltration through stimulation of the SDF-1/CXCR4 axis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1506928
Review
Published on 28 Nov 2024
Advancements in precision medicine: multi-omics approach for tailored metformin treatment in type 2 diabetes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1506767
- 339 views
Original Research
Accepted on 25 Nov 2024
Pharmacogenetic and pharmacokinetic factors for dexmedetomidine-associated hemodynamic instability in pediatric patients
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1515523
Original Research
Published on 25 Nov 2024
Comparing commercial pharmacogenetic testing results and recommendations for antidepressants with established CPIC guidelines
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1500235
- 261 views
Original Research
Published on 20 Nov 2024
Metabolic pathways, genomic alterations, and post-translational modifications in pulmonary hypertension and cancer as therapeutic targets and biomarkers
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490892
- 434 views
Review
Accepted on 19 Nov 2024
Pediatric Flecainide Pharmacogenomics: A Roadmap to Deliver Precision Based Care to Pediatrics Arrhythmias
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477485
Original Research
Published on 18 Nov 2024
Investigation on regulation of N-acetyltransferase 2 expression by nuclear receptors in human hepatocytes
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488367
- 400 views
Original Research
Published on 15 Nov 2024
Population pharmacokinetic study of the effect of polymorphisms in the ABCB1 and CES1 genes on the pharmacokinetics of dabigatran
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1454612
- 251 views
Original Research
Published on 14 Nov 2024
Novel genomic variants influencing methotrexate delayed clearance in pediatric patients with acute lymphoblastic leukemia
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1480657
- 405 views
Original Research
Accepted on 13 Nov 2024
Integration of pharmacogenetic data in Epic Genomic Module drives best practice alerts
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1458095
- 171 views
Review
Published on 12 Nov 2024
Tumor microenvironment and cancer metastasis: molecular mechanisms and therapeutic implications
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1442888
- 930 views
Original Research
Accepted on 08 Nov 2024
Paromomycin targets HDAC1-mediated SUMOylation and IGF1R translocation in glioblastoma
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1490878